PTPRC and cancer: The link between tumor and circulating hybrids is perhaps best demonstrated by the identification of the Y chromosome in CHCs (CK+/CD45+ and tumor-specific MUC4) in female recipients of sex-mismatched BMT who subsequently developed cancers [29].